$3 Billion Allocated to Expand COVID-19 Vaccinations
The National Center for Immunization and Respiratory Diseases (NCIRD) confirmed it is awarding additional supplemental funds totaling $3 billion ($3,002,304,336) to “IP19-1901 Immunization and Vaccines for Children” agreement recipients to support programs implementing and expanding COVID-19 vaccinations.
This funding is through the Coronavirus Response and Relief Supplemental Appropriations Act of 2021, P.L. 116-260.
As of May 3, 2021, the US Food and Drug Administration had not authorized experimental COVID-19 vaccines for people under 15 years of age other than clinical trial participants.
Previously, the U.S. HHS announced on March 25, 2021, it would invest more than $6 billion from the American Rescue Plan into Community Health Centers nationwide to expand COVID-19 vaccinations, testing, and treatment for vulnerable populations; deliver preventive and primary health care services to people at higher risk for COVID-19; and expand health centers’ operational capacity during the pandemic and beyond, including modifying and improving physical infrastructure and adding mobile units.
The Health Resources and Services Administration (HRSA) will provide funding starting in April to nearly 1,400 centers across the country. More than 91% of health center patients are individuals or families living at or below 200% of the Federal Poverty Guidelines, and more than 60% are racial or ethnic minorities.
For detailed information on how this HRSA funding is being distributed to health centers nationwide, including state-by-state breakdowns and an interactive health center funding map, please visit https://bphc.hrsa.gov/program-opportunities/american-rescue-plan/awards.